Terizidone (Capsules) Instructions for Use

Instructions
Dosage forms

ATC Code

J04AK03 (Terizidone)

Active Substance

Terizidone (Rec.INN WHO registered)

Clinical-Pharmacological Group

Antituberculosis drug

Pharmacotherapeutic Group

Agents active against mycobacteria; antituberculosis agents; other antituberculosis agents

Pharmacological Action

An antituberculosis antibiotic. It has a broad spectrum of antimicrobial activity. It acts bacteriostatically.

Active againstMycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium avium, as well as Staphylococcus aureus and Staphylococcus epidermidis. Also sensitive are Enterococcus faecalis, Escherichia coli, Citrobacter spp., Enterobacter spp., Morganella morganii, Klebsiella pneumoniae and Pseudomonas aeruginosa.

The development of secondary resistance is rare. No cross-resistance with other antituberculosis drugs is observed.

Pharmacokinetics

Absorption from the gastrointestinal tract is 70-90% (food intake does not affect the rate of absorption). Time to reach C_max is 2-3 hours. Effective C_min: for Mycobacterium tuberculosis – 10-40 mg/L, for staphylococci – 8-32 mg/L, for gram-negative bacteria (of clinical significance) – 20-250 mg/L.

It is well distributed in body tissues and fluids (lungs, bile, ascitic fluid, pleural effusion, synovial fluid, lymph, sputum).

It penetrates into the cerebrospinal fluid (80-100% of the serum concentration), a higher concentration in the cerebrospinal fluid is achieved with inflammatory changes in the meninges.

It is minimally metabolized.

T_1/2 is 21 hours. It is excreted by the kidneys (unchanged – 60-70%), and by the intestines (a small amount unchanged and as metabolites).

Indications

Tuberculosis of various forms and localizations as part of combination therapy for resistant forms of the disease.

ICD codes

Open the list of ICD codes

ICD-10 code	Indication
A15	Respiratory tuberculosis, bacteriologically and histologically confirmed
A17	Tuberculosis of nervous system
A18	Tuberculosis of other organs

ICD-11 code	Indication
1B10.0	Respiratory tuberculosis, bacteriologically or histologically confirmed
1B11.Z	Tuberculosis of nervous system, unspecified
1B12	Tuberculosis of other systems and organs

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Capsules

Orally.

The recommended daily dose for adults and adolescents over 14 years of age is 750-1000 mg ( for patients weighing less than 60 kg, it is recommended to take 250 mg (1 capsule) 3 times a day, for patients weighing over 60 kg – 250 mg (1 capsule) 4 times a day). The capsules are best swallowed whole with meals, with a small amount of liquid, at equal intervals throughout the day (one capsule every 6-8 hours). Intolerance to the drug can be prevented by gradually increasing the dose to the optimal level.

Adverse Reactions

Nervous system disorders headache, dizziness, increased excitability, tremor, insomnia, feeling of intoxication; in isolated cases – epileptiform convulsions, depression, psychosis.

Digestive system disorders rarely – abdominal pain, flatulence, diarrhea.

Other: allergic reactions.

Contraindications

Organic diseases of the central nervous system (including cerebrovascular sclerosis), epilepsy, mental disorders, alcoholism, pregnancy, lactation period, children under 14 years of age, hypersensitivity to terizidone.

Use in Pregnancy and Lactation

Contraindicated for use during pregnancy and lactation (breastfeeding).

Use in Renal Impairment

Use with caution in chronic renal failure.

Pediatric Use

Contraindicated in children under 14 years of age.

Geriatric Use

Use with caution in elderly patients.

Special Precautions

Use with caution in patients with chronic heart failure, in chronic renal failure, and in elderly patients.

Terizidone may cause cyanocobalamin and/or folic acid deficiency; appropriate examination and treatment are necessary.

Blood and urine parameters, liver function (ALT, AST, bilirubin) should be monitored monthly.

Patients should avoid consuming ethanol, as simultaneous use with terizidone increases the frequency of side effects (up to the development of convulsions).

Due to the possibility of developing side effects from the nervous system (depression, behavioral changes), it is necessary to monitor the patient’s mental status.

Effect on ability to drive vehicles and operate machinery

During treatment, it is necessary to refrain from driving vehicles and engaging in potentially hazardous activities that require increased concentration and speed of psychomotor reactions.

Drug Interactions

Ethanol increases the risk of epileptic seizures.

When used concomitantly with ethionamide, the risk of side effects from the central nervous system (especially convulsions) increases.

Concomitant use with isoniazid increases the frequency of dizziness and drowsiness.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Rx Only

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

Brand (or Active Substance), Marketing Authorisation Holder, Dosage Form

Terizidone [Jivdhara Pharma, Private Limited (India)]
Capsules 150 mg: 10 or 30 pcs.
Capsules 250 mg: 10 or 30 pcs.
Capsules 300 mg: 10 or 30 pcs.

Marketing Authorization Holder

Jivdhara Pharma, Private Limited (India)

Manufactured By

Scan Biotech LLC (India)

Labeled By

SCAN BIOTECH, Ltd. (India)

ROZLEX PHARM, LLC (Russia)

REDKINSKY EXPERIMENTAL PLANT, JSC (Russia)

Dosage Forms

	Terizidone	Capsules 150 mg: 10 or 30 pcs.
		Capsules 250 mg: 10 or 30 pcs.
		Capsules 300 mg: 10 or 30 pcs.

Dosage Form, Packaging, and Composition

Capsules hard, gelatin, size No. 1, cap and body brown in color. The capsule contents are a powder from white to light yellow in color.

	1 caps.
Terizidone	150 mg

Excipients : lactose monohydrate 150 mg, purified talc 20 mg.

Composition of the gelatin capsule:
Cap: titanium dioxide 1.7500%, iron (III) oxide red 0.2000%, iron (III) oxide yellow 0.0042%, gelatin 83.0958%, purified water 14.500%, sodium lauryl sulfate 0.150%, bronopol 0.100%, povidone 0.100%, methylparaben 0.075%, propylparaben 0.025%.
body: titanium dioxide 1.7500%, iron (III) oxide red 0.2000%, iron (III) oxide yellow 0.0042%, gelatin 83.0958%, purified water 14.500%, sodium lauryl sulfate 0.150%, bronopol 0.100%, povidone 0.100%, methylparaben 0.075%, propylparaben 0.025%.

10 pcs. – PVC/PVDH/Aluminum blisters (1) – cardboard packs.
10 pcs. – PVC/PVDH/Aluminum blisters (3) – cardboard packs.

Capsules hard, gelatin, size No. 0, cap and body yellow in color. The capsule contents are a powder from white to light yellow in color.

	1 caps.
Terizidone	250 mg

Excipients : lactose monohydrate 30 mg, purified talc 20 mg.

Composition of the gelatin capsule:
Cap: titanium dioxide 1.6670%, quinoline yellow dye 0.1563%, gelatin 83.2267%, purified water 14.500%, sodium lauryl sulfate 0.150%, bronopol 0.100%, povidone 0.100%, methylparaben 0.075%, propylparaben 0.025%.
body: titanium dioxide 1.7500%, quinoline yellow dye 0.1563%, gelatin 83.2267%, purified water 14.500%, sodium lauryl sulfate 0.150%, bronopol 0.100%, povidone 0.100%, methylparaben 0.075%, propylparaben 0.025%.

10 pcs. – PVC/PVDH/Aluminum blisters (1) – cardboard packs.
10 pcs. – PVC/PVDH/Aluminum blisters (3) – cardboard packs.

Capsules hard, gelatin, size No. 0, cap blue, body yellow. The capsule contents are a powder from white to light yellow in color.

	1 caps.
Terizidone	300 mg

Excipients : lactose monohydrate 35 mg, talc 15 mg.

Composition of the gelatin capsule:
Cap: titanium dioxide 1.6670%, brilliant blue dye 0.1563%, gelatin 83.2267%, purified water 14.500%, sodium lauryl sulfate 0.150%, bronopol 0.100%, povidone 0.100%, methylparaben 0.075%, propylparaben 0.025%.
body: titanium dioxide 1.7500%, brilliant blue dye 0.1563%, gelatin 83.2267%, purified water 14.500%, sodium lauryl sulfate 0.150%, bronopol 0.100%, povidone 0.100%, methylparaben 0.075%, propylparaben 0.025%.

10 pcs. – PVC/PVDH/Aluminum blisters (1) – cardboard packs.
10 pcs. – PVC/PVDH/Aluminum blisters (3) – cardboard packs.

Terizidone [Riemser Arzneimittel, AG (Germany)]
Capsules 250 mg: 50 or 500 pcs.

Marketing Authorization Holder

Riemser Arzneimittel, AG (Germany)

Manufactured By

SW Pharma GmbH (Germany)

Labeled By

L-A-W SERVICES GmbH – LEIPZIGER ARZNEIMITTELWERK (Germany)

SW PHARMA, GmbH (Germany)

Quality Control Release

SW PHARMA, GmbH (Germany)

Dosage Form

Terizidone

Capsules 250 mg: 50 or 500 pcs.

Dosage Form, Packaging, and Composition

Capsules hard gelatin, opaque, light green, size No.0; capsule contents – powder from white to slightly yellowish.

	1 caps.
Terizidone	250 mg

Excipients : lactose monohydrate – 100 mg, copovidone – 5 mg, talc – 37.5 mg, magnesium stearate – 7.5 mg.

Composition of the capsule shell gelatin – 81.33 mg, titanium dioxide (E171) – 2.29 mg, indigo carmine (indigotine) (E132) – 0.03 mg, iron (III) oxide (E172) – 0.14 mg, purified water – 14.21 mg.

10 pcs. – blisters (5) – cardboard packs.
10 pcs. – blisters (50) – cardboard packs.
10 pcs. – contour cell packs (5) – cardboard packs.
10 pcs. – contour cell packs (50) – cardboard packs.
50 pcs. – polypropylene containers (1) – cardboard packs.

Terizidone [Atoll LLC (Russia)]
Capsules 250 mg: 10, 15, 20, 30, 40, 45, 50, 60, 75, 90, 100, 135 or 150 pcs.

Marketing Authorization Holder

Atoll LLC (Russia)

Manufactured By

Ozon, LLC (Russia)

Dosage Form

Terizidone

Capsules 250 mg: 10, 15, 20, 30, 40, 45, 50, 60, 75, 90, 100, 135 or 150 pcs.

Dosage Form, Packaging, and Composition

Capsules No. 0, white body, green cap, opaque; capsule contents – a mixture of powder and granules white or white with a yellowish tint; compaction of the capsule contents into lumps that are easily destroyed when pressed is allowed.

	1 caps.
Terizidone	250 mg

Excipients : lactose monohydrate (milk sugar) – 55 mg, copovidone – 7.5 mg, talc – 5 mg, magnesium stearate – 5 mg, sodium lauryl sulfate – 2.5 mg.

Composition of the capsule body: titanium dioxide – 2%, gelatin – up to 100%.
Composition of the capsule cap azorubine dye – 0.0016%, brilliant black dye – 0.0958%, patent blue dye – 0.1642%, quinoline yellow dye – 1.1496%, titanium dioxide – 1.3333%, gelatin – up to 100%.

10 – contour cell packs (1) – cardboard packs.
10 – contour cell packs (2) – cardboard packs.
10 – contour cell packs (3) – cardboard packs.
10 – contour cell packs (4) – cardboard packs.
10 – contour cell packs (5) – cardboard packs.
10 – contour cell packs (6) – cardboard packs.
10 – contour cell packs (9) – cardboard packs.
10 – contour cell packs (10) – cardboard packs.
15 – contour cell packs (1) – cardboard packs.
15 – contour cell packs (2) – cardboard packs.
15 – contour cell packs (3) – cardboard packs.
15 – contour cell packs (4) – cardboard packs.
15 – contour cell packs (5) – cardboard packs.
15 – contour cell packs (6) – cardboard packs.
15 – contour cell packs (9) – cardboard packs.
15 – contour cell packs (10) – cardboard packs.
10 pcs. – jars – cardboard packs.
20 pcs. – jars – cardboard packs.
30 pcs. – jars – cardboard packs.
40 pcs. – jars – cardboard packs.
50 pcs. – jars – cardboard packs.
100 pcs. – jars – cardboard packs.

Terizidone [Biocom, JSC (Russia)]
Capsules 150 mg: 5, 7, 8, 10, 14, 15, 16, 20, 21, 24, 25, 30, 35, 40, 42, 48, 50, 60, 70, 80 or 100 pcs.
Capsules 250 mg: 5, 7, 8, 10, 14, 15, 16, 20, 21, 24, 25, 30, 35, 40, 42, 48, 50, 60, 70, 80 or 100 pcs.
Capsules 300 mg: 5, 7, 8, 10, 14, 15, 16, 20, 21, 24, 25, 30, 35, 40, 42, 48, 50, 60, 70, 80 or 100 pcs.

Marketing Authorization Holder

Biocom, JSC (Russia)

Dosage Forms

	Terizidone	Capsules 150 mg: 5, 7, 8, 10, 14, 15, 16, 20, 21, 24, 25, 30, 35, 40, 42, 48, 50, 60, 70, 80 or 100 pcs.
		Capsules 250 mg: 5, 7, 8, 10, 14, 15, 16, 20, 21, 24, 25, 30, 35, 40, 42, 48, 50, 60, 70, 80 or 100 pcs.
		Capsules 300 mg: 5, 7, 8, 10, 14, 15, 16, 20, 21, 24, 25, 30, 35, 40, 42, 48, 50, 60, 70, 80 or 100 pcs.

Dosage Form, Packaging, and Composition

Capsules hard, gelatin, No.0, opaque, with an orange cap and a white body; capsule contents – a mixture of granules and powder from white to white with a yellowish tint.

	1 caps.
Terizidone	150 mg

Excipients : ludipress LCE [lactose monohydrate, povidone], talc, magnesium stearate.

Composition of the gelatin capsule:
Body: gelatin, titanium dioxide E171.
cap: gelatin, titanium dioxide E171, iron oxide yellow dye.

5 pcs. – blisters (1) – cardboard packs.
5 pcs. – blisters (2) – cardboard packs.
5 pcs. – blisters (3) – cardboard packs.
5 pcs. – blisters (5) – cardboard packs.
5 pcs. – blisters (6) – cardboard packs.
5 pcs. – blisters (10) – cardboard packs.
7 pcs. – blisters (1)- cardboard packs.
7 pcs. – blisters (2) – cardboard packs.
7 pcs. – blisters (3) – cardboard packs.
7 pcs. – blisters (5) – cardboard packs.
7 pcs. – blisters (6) – cardboard packs.
7 pcs. – blisters (10) – cardboard packs.
8 pcs. – blisters (1) – cardboard packs.
8 pcs. – blisters (2) – cardboard packs.
8 pcs. – blisters (3) – cardboard packs.
8 pcs. – blisters (5) – cardboard packs.
8 pcs. – blisters (6) – cardboard packs.
8 pcs. – blisters (10) – cardboard packs.
10 pcs. – blisters (1) – cardboard packs.
10 pcs. – blisters (2) – cardboard packs.
10 pcs. – blisters (3) – cardboard packs.
10 pcs. – blisters (5) – cardboard packs.
10 pcs. – blisters (6) – cardboard packs.
10 pcs. – blisters (10) – cardboard packs.
10 pcs. – bottles – cardboard packs.
30 pcs. – bottles – cardboard packs.
50 pcs. – bottles – cardboard packs.
100 pcs. – bottles – cardboard packs.

Capsules hard, gelatin, No.0, opaque, with a dark green cap and a white body; capsule contents – a mixture of granules and powder from white to white with a yellowish tint.

	1 caps.
Terizidone	250 mg

Excipients : ludipress LCE [lactose monohydrate, povidone], talc, magnesium stearate.

Composition of the gelatin capsule:
Body: gelatin, titanium dioxide E171;
cap: gelatin, titanium dioxide E171, iron oxide yellow dye, indigo carmine (indigotine).

Capsules are hard, gelatin, size #00, opaque, with a blue cap and a white body; the capsule contents are a mixture of granules and powder ranging from white to white with a yellowish tint.

	1 caps.
Terizidone	300 mg

Excipients: Ludipress LCE [lactose monohydrate, povidone], talc, magnesium stearate.

Composition of the gelatin capsule:
Body: gelatin, titanium dioxide E171.
Cap: gelatin, titanium dioxide E171, indigotine (indigo carmine).

5 pcs. – blisters (1) – carton packs.
5 pcs. – blisters (2) – carton packs.
5 pcs. – blisters (3) – carton packs.
5 pcs. – blisters (5) – carton packs.
5 pcs. – blisters (6) – carton packs.
5 pcs. – blisters (10) – carton packs.
7 pcs. – blisters (1) – carton packs.
7 pcs. – blisters (2) – carton packs.
7 pcs. – blisters (3) – carton packs.
7 pcs. – blisters (5) – carton packs.
7 pcs. – blisters (6) – carton packs.
7 pcs. – blisters (10) – carton packs.
8 pcs. – blisters (1) – carton packs.
8 pcs. – blisters (2) – carton packs.
8 pcs. – blisters (3) – carton packs.
8 pcs. – blisters (5) – carton packs.
8 pcs. – blisters (6) – carton packs.
8 pcs. – blisters (10) – carton packs.
10 pcs. – blisters (1) – carton packs.
10 pcs. – blisters (2) – carton packs.
10 pcs. – blisters (3) – carton packs.
10 pcs. – blisters (5) – carton packs.
10 pcs. – blisters (6) – carton packs.
10 pcs. – blisters (10) – carton packs.
10 pcs. – bottles – carton packs.
30 pcs. – bottles – carton packs.
50 pcs. – bottles – carton packs.
100 pcs. – bottles – carton packs.

Terizidone [Sintez PJSC (Russia)]
Capsules 150 mg: 30, 50 or 100 pcs.
Capsules 250 mg: 30, 50, or 100 pcs.
Capsules 300 mg: 30, 50, or 100 pcs.

Marketing Authorization Holder

Sintez PJSC (Russia)

Dosage Forms

	Terizidone	Capsules 150 mg: 30, 50 or 100 pcs.
		Capsules 250 mg: 30, 50, or 100 pcs.
		Capsules 300 mg: 30, 50, or 100 pcs.

Dosage Form, Packaging, and Composition

Capsules are hard, gelatin, size #1, with a yellow body and cap; the capsule contents are a mixture of granules and powder ranging from white to light yellow or yellowish-brownish, the presence of conglomerates is allowed, which are easily destroyed when pressed.

	1 caps.
Terizidone	150 mg

Excipients: lactose monohydrate – 57.4 mg, povidone K90 – 9.3 mg, sodium carboxymethyl starch type A (sodium starch glycolate) – 2.2 mg, magnesium stearate – 1.1 mg.

Composition of the gelatin capsule:
Cap: titanium dioxide – 2%, iron oxide yellow dye – 0.629%, gelatin – up to 100%;
Body: titanium dioxide – 2%, iron oxide yellow dye – 0.629%, gelatin – up to 100%.

10 pcs. – contour cell packs (3) – carton packs.
10 pcs. – contour cell packs (5) – carton packs.
10 pcs. – contour cell packs (10) – carton packs.
30 pcs. – jars – carton packs.
50 pcs. – jars – carton packs.
100 pcs. – jars – carton packs.

Capsules are hard, gelatin, size #0, with a white body and a yellow cap; the capsule contents are a mixture of granules and powder ranging from white to light yellow or yellowish-brownish, the presence of conglomerates is allowed, which are easily destroyed when pressed.

	1 caps.
Terizidone	250 mg

Excipients: lactose monohydrate – 32.8 mg, povidone K90 – 12.7 mg, sodium carboxymethyl starch type A (sodium starch glycolate) – 3 mg, magnesium stearate – 1.5 mg.

Composition of the gelatin capsule:
Cap: titanium dioxide – 2%, iron oxide yellow dye – 0.629%, gelatin – up to 100%;
Body: titanium dioxide – 2%, gelatin – up to 100%.

Capsules are hard, gelatin, size #0, with a white body and cap; the capsule contents are a mixture of granules and powder ranging from white to light yellow or yellowish-brownish, the presence of conglomerates is allowed, which are easily destroyed when pressed.

	1 caps.
Terizidone	300 mg

Excipients: lactose monohydrate – 11.05 mg, povidone K90 – 14 mg, sodium carboxymethyl starch type A (sodium starch glycolate) – 3.3 mg, magnesium stearate – 1.65 mg.

Composition of the gelatin capsule:
Cap: titanium dioxide – 2%, gelatin – up to 100%;
Body: titanium dioxide – 2%, gelatin – up to 100%.

Terizidone [Pharmconcept, LLC (Russia)]
Capsules 150 mg: 10, 30, 100 or 500 pcs.
Capsules 250 mg: 10, 30, 100 or 500 pcs.
Capsules 300 mg: 10, 30, 100 or 500 pcs.

Marketing Authorization Holder

Pharmconcept, LLC (Russia)

Manufactured By

Vertex Exports (India)

Pharmconcept, LLC (Russia)

Labeled By

Pharmconcept, LLC (Russia)

Dosage Forms

	Terizidone	Capsules 150 mg: 10, 30, 100 or 500 pcs.
		Capsules 250 mg: 10, 30, 100 or 500 pcs.
		Capsules 300 mg: 10, 30, 100 or 500 pcs.

Dosage Form, Packaging, and Composition

Capsules are hard, gelatin, size #0, cap and body are dark burgundy color; the capsule contents are granules or powder ranging from white to yellowish-white.

	1 caps.
Terizidone	150 mg

Excipients: microcrystalline cellulose – 20 mg, disodium edetate dihydrate – 2 mg, hypromellose – 1.8 mg, magnesium stearate – 2.2 mg.

Composition of the gelatin capsule:
Cap: gelatin – 31.1 mg, methylparaben – 0.181 mg, propylparaben – 0.045 mg, colloidal silicon dioxide – 0.189 mg, bronopol – 0.019 mg, sodium lauryl sulfate – 0.057 mg, glycerol – 0.038 mg, titanium dioxide – 0.567 mg, iron oxide red dye 0.815 mg, iron oxide black dye – 0.108 mg, water – q.s.
Body: gelatin – 55.3 mg, methylparaben – 0.277 mg, propylparaben – 0.069 mg, colloidal silicon dioxide – 0.289 mg, bronopol – 0.029 mg, sodium lauryl sulfate – 0.087 mg, glycerol – 0.058 mg, titanium dioxide – 0.867 mg, iron oxide red dye 1.02 mg, iron oxide black dye – 0.215 mg, water – q.s.

10 pcs. – strips (1) – carton packs.
10 pcs. – strips (3) – carton packs.
10 pcs. – strips (10) – carton packs.
30 pcs. – polyethylene bags (1) – plastic jars.
100 pcs. – polyethylene bags (1) – plastic jars.
500 pcs. – polyethylene bags (1) – plastic jars.
10 pcs. – aluminum strips (100) – carton boxes (for hospitals).
100 pcs. – polyethylene bags (1) – plastic jars (10) – carton boxes (for hospitals).

Capsules are hard, gelatin, size #00, cap and body are blue color; the capsule contents are granules or powder ranging from white to yellowish-white.

	1 caps.
Terizidone	250 mg

Excipients: microcrystalline cellulose – 40.8 mg, disodium edetate dihydrate – 3.4 mg, hypromellose – 2.4 mg, magnesium stearate – 3.4 mg.

Composition of the gelatin capsule:
Cap: gelatin – 41.7 mg, methylparaben – 0.22 mg, propylparaben – 0.055 mg, colloidal silicon dioxide – 0.229 mg, bronopol – 0.023 mg, sodium lauryl sulfate – 0.069 mg, glycerol – 0.046 mg, titanium dioxide – 0.916 mg, brilliant blue dye – 0.03 mg, water – q.s.
Body: gelatin – 66.1 mg, methylparaben – 0.347 mg, propylparaben – 0.087 mg, colloidal silicon dioxide – 0.217 mg, bronopol – 0.036 mg, sodium lauryl sulfate – 0.108 mg, glycerol – 0.072 mg, titanium dioxide – 1.444 mg, brilliant blue dye – 0.047 mg, water – q.s.

Capsules are hard, gelatin, size #00, cap is blue color and body is dark blue color; the capsule contents are granules or powder ranging from white to yellowish-white.

	1 caps.
Terizidone	300 mg

Excipients: microcrystalline cellulose – 30.8 mg, disodium edetate dihydrate – 3.4 mg, hypromellose – 2.4 mg, magnesium stearate – 3.4 mg.

Composition of the gelatin capsule:
Cap: gelatin – 41.7 mg, methylparaben – 0.22 mg, propylparaben – 0.055 mg, colloidal silicon dioxide – 0.229 mg, bronopol – 0.023 mg, sodium lauryl sulfate – 0.069 mg, glycerol – 0.046 mg, titanium dioxide – 0.55 mg, brilliant blue dye – 0.17 mg, water – q.s.
Body: gelatin – 66.1 mg, methylparaben – 0.347 mg, propylparaben – 0.087 mg, colloidal silicon dioxide – 0.217 mg, bronopol – 0.036 mg, sodium lauryl sulfate – 0.108 mg, glycerol – 0.072 mg, titanium dioxide – 0.866 mg, brilliant blue dye – 0.5 mg, azorubine dye – 0.109, water – q.s.

Medixlife (Author)

View all posts Profile link